Raffaele Colombo
LightNews LightNews
banner
raffcolo.bsky.social
Raffaele Colombo
@raffcolo.bsky.social
200 followers 150 following 10 posts
ADCs, targeted therapies, chemistry, biotech, pharma.
Associate Director @ Zymeworks
Posts Replies Media Videos
raffcolo.bsky.social
For a summary of how ADC payload class has evolved over time (up to August 2024), see: aacrjournals.org/cancerdiscov...
December 24, 2024 at 4:51 PM
raffcolo.bsky.social
www.prnewswire.com/news-release...
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC
/PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from...
www.prnewswire.com
November 27, 2024 at 4:11 PM
raffcolo.bsky.social
Congrats!!
November 20, 2024 at 6:13 PM